- Home
- GRF vs CCEL Comparison
GRF vs CCEL Comparison
Compare GRF & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRF
- CCEL
- Stock Information
- Founded
- GRF 1989
- CCEL 1989
- Country
- GRF United States
- CCEL United States
- Employees
- GRF N/A
- CCEL N/A
- Industry
- GRF Finance/Investors Services
- CCEL Managed Health Care
- Sector
- GRF Finance
- CCEL Health Care
- Exchange
- GRF Nasdaq
- CCEL Nasdaq
- Market Cap
- GRF 39.3M
- CCEL 36.7M
- IPO Year
- GRF N/A
- CCEL 1997
- Fundamental
- Price
- GRF $10.43
- CCEL $4.40
- Analyst Decision
- GRF
- CCEL Strong Buy
- Analyst Count
- GRF 0
- CCEL 1
- Target Price
- GRF N/A
- CCEL $8.50
- AVG Volume (30 Days)
- GRF 3.0K
- CCEL 13.2K
- Earning Date
- GRF 01-01-0001
- CCEL 10-14-2025
- Dividend Yield
- GRF 3.70%
- CCEL 13.64%
- EPS Growth
- GRF N/A
- CCEL N/A
- EPS
- GRF 1.16
- CCEL N/A
- Revenue
- GRF N/A
- CCEL $31,988,783.00
- Revenue This Year
- GRF N/A
- CCEL $1.75
- Revenue Next Year
- GRF N/A
- CCEL N/A
- P/E Ratio
- GRF $8.15
- CCEL N/A
- Revenue Growth
- GRF N/A
- CCEL 1.10
- 52 Week Low
- GRF $7.93
- CCEL $4.09
- 52 Week High
- GRF $10.19
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- GRF 65.01
- CCEL 43.95
- Support Level
- GRF $9.95
- CCEL $4.21
- Resistance Level
- GRF $10.98
- CCEL $4.65
- Average True Range (ATR)
- GRF 0.12
- CCEL 0.23
- MACD
- GRF 0.07
- CCEL -0.01
- Stochastic Oscillator
- GRF 76.70
- CCEL 36.02
About GRF Eagle Capital Growth Fund Inc.
Eagle Capital Growth Fund Inc is a diversified closed-end investment company. The fund's objective is long-term growth utilizing the concept of total return for selecting investments. It seeks to achieve its investment objectives by investing predominantly in U.S. issuer common stock by giving preference to high-quality companies, where high quality denotes substantial operating income margins, high returns on capital, and robust balance sheets.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.